Shirley Behar - Infimer External Director
| INFR Stock | ILA 1.50 24,498 99.99% |
Director
Ms. Shirley Behar was appointed External Director at Infimer Ltd effective July 25, 2018. Her work experience includes the following roles Vice PresidentProduct and Marketing at PointGrab Ltd and Product Manager at Intel Corporationration. She holds a BS degree in Computer Science from The Technion Israel Institute of Technology and a MBA degree, majoring in Finance and Entrepreneurship, from University of Chicago. since 2018.
| Age | 38 |
| Tenure | 6 years |
| Professional Marks | MBA |
| Phone | 972 73 700 0266 |
| Web | http://www.infimer.com |
Infimer Management Efficiency
The company has return on total asset (ROA) of (0.3287) % which means that it has lost $0.3287 on every $100 spent on assets. This is way below average. Infimer's management efficiency ratios could be used to measure how well Infimer manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 12 records | DIRECTOR Age | ||
| Moshe Shimoni | Aura Investments | 47 | |
| Dalit Barak | Analyst IMS Investment | 37 | |
| Yosef Itzhak | Hiron Trade Investments Industr | 63 | |
| Avi Drechsler | Analyst IMS Investment | 57 | |
| Imik Levi | Hiron Trade Investments Industr | 62 | |
| Edith Mor | Aura Investments | 41 | |
| Naomi Shapiro | Analyst IMS Investment | 39 | |
| Efraim Avraham | Analyst IMS Investment | 64 | |
| Nava Shaffer | Aura Investments | ||
| Avraham Ortal | Aura Investments | 50 | |
| Liat Tzaig | Aura Investments | 32 | |
| Avital Babler | Aura Investments | 36 | |
Management Performance
| Return On Asset | -0.33 |
Infimer Leadership Team
Elected by the shareholders, the Infimer's board of directors comprises two types of representatives: Infimer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Infimer. The board's role is to monitor Infimer's management team and ensure that shareholders' interests are well served. Infimer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Infimer's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Moshe Dayan, Chief Executive Officer | ||
| Asaf Tennenbaum, External Director | ||
| Gosta Tixell, Independent Director | ||
| Shirley Behar, External Director | ||
| Avshalom Shilin, Director | ||
| Yuval Tamir, Chairman of the Board, CEO | ||
| Batya Many, Vice President - Finance | ||
| Tal Tamir, Director | ||
| Eliahu Zahavi, Director | ||
| Oren Zahavi, Vice President - Business Development |
Infimer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Infimer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.33 | |||
| Operating Margin | (9.80) % | |||
| Current Valuation | 25.15 M | |||
| Shares Outstanding | 1.06 M | |||
| Shares Owned By Insiders | 14.32 % | |||
| Shares Owned By Institutions | 10.35 % | |||
| Price To Earning | (867.76) X | |||
| Price To Sales | 4,759 X | |||
| Revenue | 378 K | |||
| Gross Profit | (899 K) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Infimer Stock
Infimer financial ratios help investors to determine whether Infimer Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Infimer with respect to the benefits of owning Infimer security.